BE806946A - Compositions pharmaceutiques contenant des inhibiteurs de la xanthine oxydase - Google Patents

Compositions pharmaceutiques contenant des inhibiteurs de la xanthine oxydase

Info

Publication number
BE806946A
BE806946A BE137437A BE137437A BE806946A BE 806946 A BE806946 A BE 806946A BE 137437 A BE137437 A BE 137437A BE 137437 A BE137437 A BE 137437A BE 806946 A BE806946 A BE 806946A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
compositions containing
xanthine oxidase
oxidase inhibitors
containing xanthine
Prior art date
Application number
BE137437A
Other languages
English (en)
French (fr)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BE806946A publication Critical patent/BE806946A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE137437A 1972-11-06 1973-11-05 Compositions pharmaceutiques contenant des inhibiteurs de la xanthine oxydase BE806946A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5105072A GB1445983A (en) 1972-11-06 1972-11-06 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
BE806946A true BE806946A (fr) 1974-05-06

Family

ID=10458450

Family Applications (1)

Application Number Title Priority Date Filing Date
BE137437A BE806946A (fr) 1972-11-06 1973-11-05 Compositions pharmaceutiques contenant des inhibiteurs de la xanthine oxydase

Country Status (14)

Country Link
JP (1) JPS577127B2 (US07118763-20061010-C00002.png)
AU (1) AU467532B2 (US07118763-20061010-C00002.png)
BE (1) BE806946A (US07118763-20061010-C00002.png)
CA (1) CA975297A (US07118763-20061010-C00002.png)
CH (1) CH583734A5 (US07118763-20061010-C00002.png)
CY (1) CY940A (US07118763-20061010-C00002.png)
DE (1) DE2355204A1 (US07118763-20061010-C00002.png)
FR (1) FR2205309B1 (US07118763-20061010-C00002.png)
GB (1) GB1445983A (US07118763-20061010-C00002.png)
HK (1) HK1278A (US07118763-20061010-C00002.png)
IL (1) IL43562A (US07118763-20061010-C00002.png)
KE (1) KE2807A (US07118763-20061010-C00002.png)
MY (1) MY7800180A (US07118763-20061010-C00002.png)
ZA (1) ZA738489B (US07118763-20061010-C00002.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
FR2608045B1 (fr) * 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors

Also Published As

Publication number Publication date
CY940A (en) 1978-06-23
KE2807A (en) 1978-02-17
CH583734A5 (US07118763-20061010-C00002.png) 1977-01-14
AU467532B2 (en) 1975-12-04
DE2355204A1 (de) 1974-05-16
FR2205309B1 (US07118763-20061010-C00002.png) 1976-04-09
JPS49133517A (US07118763-20061010-C00002.png) 1974-12-21
CA975297A (en) 1975-09-30
HK1278A (en) 1978-01-13
JPS577127B2 (US07118763-20061010-C00002.png) 1982-02-09
IL43562A0 (en) 1974-03-14
GB1445983A (en) 1976-08-11
ZA738489B (en) 1975-02-26
AU6217773A (en) 1975-05-08
IL43562A (en) 1976-08-31
MY7800180A (en) 1978-12-31
FR2205309A1 (US07118763-20061010-C00002.png) 1974-05-31

Similar Documents

Publication Publication Date Title
IT1051562B (it) Composizione per substrati per la determinazione quantitativa di enzimi
SE413266B (sv) Ureashaltig indikator for pavisande av karbamid
FR2290912A1 (fr) Formulations pharmaceutiques contenant de la l-dopa ou ses derives
BE772190A (fr) Nouvelles compositions pharmaceutiques
BE823689A (fr) Compositions pharmaceutiques
BE772723A (fr) Procede de preparation de nouvelles alpha-aminopenicillines, penicillines ainsi obtenues et compositions pharmaceutiques les contenant
IT987645B (it) Ottenimento di colesterinossi dasi
BE798265A (fr) Compositions detergentes contenant des enzymes
BE814546A (fr) Nouvelles cephalosporines et compositions pharmaceutiques en contenant
BE782981A (fr) Compositions pharmaceutiques
BE800383A (fr) Composition desensibilisatrice
BE815499A (fr) Compositions pharmaceutiques contenant des derives de triazolo-isoquinoleine
IL43766A0 (en) Pharmaceutical compositions containing bis-phenolalkane derivatives
BE815409A (fr) Compositions pharmaceutiques contenant des inhibiteurs de la xanthine oxydase
BE775232A (fr) Inhibiteurs de corrosion contenant des derives de benzotriazole
BE806946A (fr) Compositions pharmaceutiques contenant des inhibiteurs de la xanthine oxydase
BE795132A (fr) Composition a usage medical veterinaire ou cosmetologique contenant un pyrocarbonate difthylique
SE404813B (sv) Glodskalinhibitorkomposition
BE782444A (fr) Compositions pharmaceutiques
BE806246A (fr) Compositions pharmaceutiques contenant des sels de sulfoglycopeptides
BE764768A (fr) Compositions pharmaceutiques
BE808738A (fr) Composition desensibilisatrice
BE797215A (fr) Composition contenant de la protease
FR2315276A1 (fr) Compositions pharmaceutiques contenant des tetrahydroisoquinoleines substituees
BE772487A (fr) Compositions pharmaceutiques

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: THE WELLCOME FOUNDATION LTD

Effective date: 19931105